CT-388
A Study of Enicepatide (CT-388) in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
Roche · Phase 2 · Completed · Enrollment 469
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.